HOME >> BIOLOGY >> NEWS
Early promise for treatment of Ebola

Preliminary findings of an animal study in this week's issue of THE LANCET suggest that scientists have taken an important step towards a possible treatment strategy for the deadly Ebola virus.

Haemorragic fever from the Ebola virus is fatal in up to 80%of cases in humans. The virus is thought to cause excessive blood coagulation and thrombosis leading to organ dysfunction. Inhibition of the blood coagulation pathway could therefore be a potential therapeutic approach for ebola treatment.

Thomas W Geisbert from the US Army Medical Research Institute of Infectious Diseases and colleagues injected 12 rhesus macaques with the ebola virus to induce the deadly ebola haemorragic fever. Nine of the macaques received an inhibitor of the blood coagulation pathway (called recombinant nematode anticoagulant protein c2, rNAPc2), while three macaques received the ebola virus only (the control group).

Treatment with rNAPc2 prolonged survival time and resulted in a 33% survival rate; this contrasted with macaques in the control group, of whom all except one died (since the study was completed the remaining control animal has also died). The surviving macaques in the treatment group were in good health nine months after the study. Survival was longer (12 days) for treated macaques who died compared with untreated macaques in the control group (8 days).

Thomas W Geisbert comments: "Our results have great clinical implications, since our treatment approach of Ebola haemorrhagic fever targets the disease process rather than replication of the infectious agent. Moreover, our findings raise the possibility that rNAPc2 could be useful in the treatment of other viral haemorrhagic fevers. Importantly, rNAPc2 has a suitable phamacokinetic and safety profile in human beings. The clinical efficacy of this treatment modality now needs to be proven."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
11-Dec-2003


Page: 1

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early treatment can prevent severe vision loss in premature infants
9. Early hominids may have behaved more human than we had thought
10. Early infection and rejection detection
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... 15, 2019 , ... Deep Science Ventures (DSV), a new paradigm ... new unit dedicated to building 100 companies over the next 10 years to address ... , Deep Science Ventures was founded to create a better method for launching ...
(Date:8/15/2019)... ARLINGTON, Va. (PRWEB) , ... August 15, 2019 ... ... best serve patients, and relieve lab staff of routine tasks. That was the ... month, according to market researcher Kalorama Information. The American Association for Clinical Chemistry ...
(Date:8/14/2019)... MARTINSRIED, Germany (PRWEB) , ... August 14, 2019 ... ... screening and characterization, announced today that they have opened a Customer Experience Center ... fueled the need for the new office. , The Munich CEC will be ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las Vegas ... Heroes Program. The Veterans included individuals and families from all over the US, with ... military Veteran, teacher or first responder to receive a regenerative therapy at a training ...
(Date:7/2/2019)... ... 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , ... The film focuses on regenerative veterinary medicine as a means of improving the ... included in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, ... Drug (IND) application to the FDA for use of a person’s own adipose-derived stem ... treatment of osteoarthritis in the knee. This IND is the first of several ...
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted Danson ... scheduled to broadcast 4Q/2019. Check your local listings for more information. , Advancements ... how its technology facilitates laboratories to improve efficiency and quality of research by ...
Breaking Biology Technology:
Cached News: